Current value sales for analgesics are set to remain fairly stable during the forecast period, though will still be higher than was recorded pre-pandemic. Volume sales will suffer, as the category’s expansion constrained by the level of maturity that it has already achieved.
Topical analgesics, which saw unit price growth negatively affected by Teva Finland’s Diclofenac Ratiopharm launch, is starting to show signs of unit price growth again. There is an expanding range of alternative products based on natural ingredients, such as Voltnatura from GSK Consumer Healthcare.
Paediatric analgesics is expected to perform well during the forecast period. Parents are increasingly looking for child-specific products and becoming more confident in self-medication when it comes to their children.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Understand the latest market trends and future growth opportunities for the Analgesics industry in Finland with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Finland, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See All of Our DefinitionsThis report originates from Passport, our Analgesics research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!